Abstract
Metastatic brain tumors are a serious complication of systemic cancer whose annual incidence of over 100,000 continues to rise. Conventional surgery and stereotactic radiosurgery (SRS) each have benefits in the treatment of brain metastases. The advantages of surgery include immediate resolution of mass effect, procurement of tissue for pathological diagnosis, and avoidance of radiation necrosis. The advantages of SRS include decreased risk of hemorrhage and infection and no risk of tumor seeding. SRS is also less invasive, potentially less costly, and requires shorter hospital stays than standard craniotomy. The disadvantages of SRS include potential exacerbation of peritumoral edema, a requirement for long-term steroid administration, and possible radiation necrosis. At The University of Texas M.D. Anderson Cancer Center, surgical resection plays a central role in the management of metastatic brain tumors. SRS is largely reserved for patients who are not candidates for surgery. We believe that a complementary approach employing surgery, whole-brain radiation therapy, and SRS in patients with brain metastasis is best and will continue to evolve.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol. 1978;19:579–92.
Tsukada Y, Fouad A, Pickren JW, Lane WW. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer. 1983;52(12):2349–54.
Sawaya R, Bindal RK, Lang FF, Suki D. Metastatic brain tumors. In: Kaye AH, Laws ER, editors. Brain tumors: an encyclopedic approach. 3rd ed. London: Elsevier Saunders; 2011. p. 864–92.
Sawaya R. Surgical treatment of brain metastases. Clin Neurosurg. 1999;45:41–7.
Young RF. Radiosurgery for the treatment of brain metastases. Semin Surg Oncol. 1998;14(1):70–8.
Grant FC. Concerning intracranial malignant metastases: their frequency and the value of surgery in their treatment. Ann Surg. 1926;84:635–46.
Cairncross JG, Posner JB. The management of brain metastases. In: Walker MD, editor. Oncology of the nervous system. Boston: Martinus Nijhof; 1983. p. 341–77.
Horwitz NH, Rizzoli HV. Postoperative complications of intracranial neurological surgery. Baltimore: Williams & Wilkins; 1982.
Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980;6(1):1–9.
Diener-West M, Dobbins TW, Phillips TL, Nelson DF. Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys. 1989;16(3):669–73.
Sneed PK, Larson DA, Wara WM. Radiotherapy for cerebral metastases. Neurosurg Clin N Am. 1996;7(3):505–15.
Noordijk EM, Vecht CJ, Haaxma-Reiche H, Padberg GW, Voormolen JH, Hoekstra FH, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys. 1994;29(4):711–7.
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322(8): 494–500.
Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand. 1951;102:316–9.
Leksell L. Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry. 1983;46(9):797–803.
Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA, et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys. 1996;35(1):27–35.
Flickinger JC, Kondziolka D. Radiosurgery instead of resection for solitary brain metastasis: the gold standard redefined. Int J Radiat Oncol Biol Phys. 1996;35(1):185–6.
Hasegawa T, Kondziolka D, Flickinger JC, Germanwala A, Lunsford LD. Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery. 2003;52(6): 1318–26.
Lutterbach J, Cyron D, Henne K, Ostertag CB. Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery. 2003;52(5):1066–73.
Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys. 2002; 53(3):519–26.
Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. J Neurosurg. 1993;79(2):210–6.
Bindal RK, Sawaya R, Leavens ME, Hess KR, Taylor SH. Reoperation for recurrent metastatic brain tumors. J Neurosurg. 1995;83(4):600–4.
Bindal AK, Bindal RK, Hess KR, Shiu A, Hassenbusch SJ, Shi WM, et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg. 1996;84(5):748–54.
Dare AO, Sawaya R. Part II: Surgery versus radiosurgery for brain metastasis: surgical advantages and radiosurgical myths. Clin Neurosurg. 2004;51:255–63.
Mehta MP, Rozental JM, Levin AB, Mackie TR, Kubsad SS, Gehring MA, et al. Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys. 1992;24(4):619–25.
Chang EL, Hassenbusch 3rd SJ, Shiu AS, Lang FF, Allen PK, Sawaya R, et al. The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery. 2003;53(2):272–80.
Regine WF, Huhn JL, Patchell RA, St Clair WH, Strottmann J, Meigooni A, et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys. 2002;52(2):333–8.
Selek U, Chang EL, Hassenbusch 3rd SJ, Shiu AS, Lang FF, Allen P, et al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys. 2004;59(4):1097–106.
Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;45(2):427–34.
Shehata MK, Young B, Reid B, Patchell RA, St Clair W, Sims J, et al. Stereotactic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys. 2004;59(1):87–93.
Cho KH, Hall WA, Lee AK, Gerbi BJ, Higgins PD, Bohen M, et al. Stereotactic radiosurgery for patients with single brain metastasis. J Radiosurg. 1998;1(2):79–85.
O’Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O’Fallon JR. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys. 2003;55(5):1169–76.
Vecil GG, Suki D, Maldaun MV, Lang FF, Sawaya R. Resection of brain metastases previously treated with stereotactic radiosurgery. J Neurosurg. 2005;102(2):209–15.
Alexander 3rd E, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst. 1995;87(1):34–40.
Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys. 1994;28(4):797–802.
Kihlstrom L, Karlsson B, Lindquist C, Noren G, Rahn T. Gamma knife surgery for cerebral metastasis. Acta Neurochir Suppl (Wien). 1991;52:87–9.
Muacevic A, Kreth FW, Horstmann GA, Schmid-Elsaesser R, Wowra B, Steiger HJ, et al. Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg. 1999;91(1):35–43.
Petrovich Z, Yu C, Giannotta SL, O’Day S, Apuzzo ML. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg. 2002;97(5 Suppl): 499–506.
Voorhies RM, Sundaresan N, Thaler HT. The single supratentorial lesion. An evaluation of preoperative diagnostic tests. J Neurosurg. 1980;53(3):364–8.
Mehta M, Noyes W, Craig B, Lamond J, Auchter R, French M, et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys. 1997;39(2):445–54.
Rutigliano MJ, Lunsford LD, Kondziolka D, Strauss MJ, Khanna V, Green M. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery. 1995;37(3):445–53.
Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37(4):745–51.
Epstein BE, Scott CB, Sause WT, Rotman M, Sneed PK, Janjan NA, et al. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28. Cancer. 1993;71(4): 1362–7.
Murray KJ, Scott C, Greenberg HM, Emami B, Seider M, Vora NL, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys. 1997;39(3):571–4.
Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037–44.
Chang EL, Wefel JS, Maor MH, Hassenbusch 3rd SJ, Mahajan A, Lang FF, et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery. 2007;60(2):277–83.
Szeifert GT, Massager N, DeVriendt D, David P, De Smedt F, Rorive S, et al. Observations of intracranial neoplasms treated with gamma knife radiosurgery. J Neurosurg. 2002;97(5 Suppl):623–6.
Loeffler JS, Alexander 3rd E. Radiosurgery for the treatment of intracranial metastases. In: Alexander 3rd E, Loeffler JS, Lunsford LD, editors. Stereotactic radiosurgery. New York: McGraw-Hill; 1993. p. 197–206.
Sturm V, Kimmig B, Engenhardt R, Schlegel W, Pastyr O, Treuer H, et al. Radiosurgical treatment of cerebral metastases. Method, indications and results. Stereotact Funct Neurosurg. 1991;57(1–2): 7–10.
Kondziolka D, Lunsford LD. Brain metastases. In: Apuzzo MLJ, editor. Brain surgery: complication avoidance and management. New York: Churchill Livingstone Inc.; 1993. p. 615–41.
Acknowledgment
We thank the Barbara Falik Research Fund for helping make this work possible.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sawaya, R., Wildrick, D.M., Mesfin, F.B. (2015). Metastatic Brain Tumors:Viewpoint—Surgery. In: Chin, L., Regine, W. (eds) Principles and Practice of Stereotactic Radiosurgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8363-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8363-2_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8362-5
Online ISBN: 978-1-4614-8363-2
eBook Packages: MedicineMedicine (R0)